OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial
Yasuhiro Hagiwara, Masataka Sawaki, Yukari Uemura, et al.
Breast Cancer Research and Treatment (2021) Vol. 188, Iss. 3, pp. 675-683
Closed Access | Times Cited: 6
Yasuhiro Hagiwara, Masataka Sawaki, Yukari Uemura, et al.
Breast Cancer Research and Treatment (2021) Vol. 188, Iss. 3, pp. 675-683
Closed Access | Times Cited: 6
Showing 6 citing articles:
Cost-effectiveness analysis of trastuzumab monotherapy versus adjuvant chemotherapy plus trastuzumab in elderly patients with HER2-positive early breast cancer
Takaaki Konishi, Michimasa Fujiogi, Nobuaki Michihata, et al.
Japanese Journal of Clinical Oncology (2022) Vol. 52, Iss. 10, pp. 1115-1123
Closed Access | Times Cited: 10
Takaaki Konishi, Michimasa Fujiogi, Nobuaki Michihata, et al.
Japanese Journal of Clinical Oncology (2022) Vol. 52, Iss. 10, pp. 1115-1123
Closed Access | Times Cited: 10
The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer
Wen Li, Qianqian Zhang, Yinlian Cai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Wen Li, Qianqian Zhang, Yinlian Cai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
Masataka Sawaki, Naruto Taira, Yukari Uemura, et al.
The Breast (2022) Vol. 66, pp. 245-254
Open Access | Times Cited: 7
Masataka Sawaki, Naruto Taira, Yukari Uemura, et al.
The Breast (2022) Vol. 66, pp. 245-254
Open Access | Times Cited: 7
Executive Functions and Public Health: A Narrative Review
M Esmaili, Dariush D Farhud, Kambiz Poushaneh, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 1
M Esmaili, Dariush D Farhud, Kambiz Poushaneh, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 1
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: a propensity score-adjusted analysis of a prospective cohort study
Masataka Sawaki, Naruto Taira, Yukari Uemura, et al.
Research Square (Research Square) (2022)
Open Access
Masataka Sawaki, Naruto Taira, Yukari Uemura, et al.
Research Square (Research Square) (2022)
Open Access
Adjuvant Trastuzumab Without Chemotherapy For Treating Early HER2-Positive Breast Cancer In Older Patients: A Cohort Study Accompanying With The RESPECT Trial
Masataka Sawaki, Naruto Taira, Yukari Uemura, et al.
Research Square (Research Square) (2021)
Open Access
Masataka Sawaki, Naruto Taira, Yukari Uemura, et al.
Research Square (Research Square) (2021)
Open Access
